Conseil en développement de médicaments

Orphan Drug Designations (ODD)

Orphan Drug Designations (ODD)

The EMA and FDA provide specific incentives to companies who are granted Orphan Drug Designation for their product.

We can determine if your product is eligible for orphan drug designation and provide the necessary support for your application to both the EMA and the FDA to ensure rapid seamless approval.


Discover our last white Paper

Learn more